Table 4. Nasalance change in wide opening functional endoscopic sinus surgery group
Pre-FESS Post-FESS 6M p-value Post-FESS 12 M p-value
[a] 24.0 (18.5-41) 30.0 (15.5-38.0) 0.94 34.0 (17.0-49.0) 0.23
[i] 28.0 (17.0-54.5) 40.0 (29.5-58.0) 0.05 40.0 (29.0-63.5) 0.02*
[u] 12.0 (9.0-22.0) 13.0 (11.0-21.5) 0.46 13.0 (10.0-35.0) 0.27
[m] 95.0 (89.0-96.0) 96.0 (94.0-96.0) 0.35 96.0 (94.5-96.5) 0.04*
[MaMa] 59.0 (42.5-65.0) 59.0 (52.5-67.5) 0.34 59.0 (43.0-65.0) 0.28
[MiMi] 81.0 (71.5-89.0) 86.5 (81.0-90.5) 0.12 88.0 (81.5-90.5) 0.04*
[Oral sentence] 10.0 (8.5-14.0) 10.0 (7.5-17.0) 0.35 13.0 (8.5-23.0) 0.12
[Nasal sentence] 64.0 (48.5-70.0) 63.0 (56.0-74.0) 0.21 64.5 (53.5-74.0) 0.16
Data are presented as median and interquartile range. Wilcoxon signed rank test was used to assess significant intergroup variability. * p< 0.05, significant. FESS: functional endoscopic sinus surgery. Data are presented as median and interquartile range. Wilcoxon signed rank test was used to assess significant intergroup variability. * p< 0.05, significant. FESS: functional endoscopic sinus surgery. Data are presented as median and interquartile range. Wilcoxon signed rank test was used to assess significant intergroup variability. * p< 0.05, significant. FESS: functional endoscopic sinus surgery. Data are presented as median and interquartile range. Wilcoxon signed rank test was used to assess significant intergroup variability. * p< 0.05, significant. FESS: functional endoscopic sinus surgery. Data are presented as median and interquartile range. Wilcoxon signed rank test was used to assess significant intergroup variability. * p< 0.05, significant. FESS: functional endoscopic sinus surgery. Data are presented as median and interquartile range. Wilcoxon signed rank test was used to assess significant intergroup variability. * p< 0.05, significant. FESS: functional endoscopic sinus surgery.